The Cost-Effectiveness of CT Colonography in Screening for Colorectal Neoplasia
dc.contributor.author | Vijan, Sandeep | en_US |
dc.contributor.author | Hwang, Inku | en_US |
dc.contributor.author | Inadomi, John M. | en_US |
dc.contributor.author | Wong, Roy K. H. | en_US |
dc.contributor.author | Choi, J. Richard | en_US |
dc.contributor.author | Napierkowski, John | en_US |
dc.contributor.author | Koff, Jonathan M. | en_US |
dc.contributor.author | Pickhardt, Perry J. | en_US |
dc.date.accessioned | 2010-06-01T18:20:06Z | |
dc.date.available | 2010-06-01T18:20:06Z | |
dc.date.issued | 2007-02 | en_US |
dc.identifier.citation | Vijan, Sandeep; Hwang, Inku; Inadomi, John; Wong, Roy K.H.; Choi, J. Richard; Napierkowski, John; Koff, Jonathan M.; Pickhardt, Perry J. (2007). "The Cost-Effectiveness of CT Colonography in Screening for Colorectal Neoplasia." The American Journal of Gastroenterology 102(2): 380-390. <http://hdl.handle.net/2027.42/71544> | en_US |
dc.identifier.issn | 0002-9270 | en_US |
dc.identifier.issn | 1572-0241 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/71544 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17156139&dopt=citation | en_US |
dc.format.extent | 218772 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Inc | en_US |
dc.rights | 2007 by Am. Coll. of Gastroenterology | en_US |
dc.title | The Cost-Effectiveness of CT Colonography in Screening for Colorectal Neoplasia | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Veterans Affairs Health Services Research and Development Center for Practice Management and Outcomes Research, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationother | Department of Internal Medicine, Walter Reed Army Medical Center, Washington, DC | en_US |
dc.contributor.affiliationother | Department of Internal Medicine, University of California, San Francisco, California | en_US |
dc.contributor.affiliationother | Department of Radiology, Walter Reed Army Medical Center, Washington, DC | en_US |
dc.contributor.affiliationother | Department of Radiology, F. Edward Hebert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland | en_US |
dc.contributor.affiliationother | Department of Radiology, University of Wisconsin Medical School, Madison, Wisconsin | en_US |
dc.identifier.pmid | 17156139 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/71544/1/j.1572-0241.2006.00970.x.pdf | |
dc.identifier.doi | 10.1111/j.1572-0241.2006.00970.x | en_US |
dc.identifier.source | The American Journal of Gastroenterology | en_US |
dc.identifier.citedreference | Parker SL, Tong T, Bolden S, et al. Cancer statistics, 1996. CA Cancer J Clin 1996; 46: 5 – 27. | en_US |
dc.identifier.citedreference | Ries LAG, Kosary CL, Hankey BF, et al. SEER Cancer Statistics Review, 1973–1996. 99. Bethesda, MD, National Cancer Institute. | en_US |
dc.identifier.citedreference | Morson BC. The evolution of colorectal carcinoma. Clin Radiol 1984; 35: 425 – 31. | en_US |
dc.identifier.citedreference | Muto T, Bussey HJR, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36: 2251 – 70. | en_US |
dc.identifier.citedreference | Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992; 326: 658 – 62. | en_US |
dc.identifier.citedreference | Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993; 329: 1977 – 81. | en_US |
dc.identifier.citedreference | Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: Clinical guidelines and rationale—Update based on new evidence. Gastroenterology 2003; 124: 544 – 60. | en_US |
dc.identifier.citedreference | Cram P, Inadomi J, Cowen ME, et al. The impact of a healthy celebrity spokesperson on preventive health behavior: The Katie couric effect. Arch Int Med 2003; 163: 1601 – 5. | en_US |
dc.identifier.citedreference | Vernon SW. Participation in colorectal cancer screening: A review. J Natl Cancer Inst 1997; 89: 1406 – 22. | en_US |
dc.identifier.citedreference | Seeff L, Nadel M, Blackman D, Pollack LA. Colorectal cancer test use among persons aged 50 years and older–United States, 2001. MMWR 2003; 52: 193 – 6. | en_US |
dc.identifier.citedreference | Hynam KA, Hart AR, Gay SP, et al. Screening for colorectal cancer: reasons for refusal of faecal occult blood testing in a general practice in England. J Epidemiol Community Health 1995; 49: 84 – 6. | en_US |
dc.identifier.citedreference | Harewood GC, Wiersema MJ, Melton LJ 3rd. A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy. Am J Gastroenterol 2002; 97: 3186 – 94. | en_US |
dc.identifier.citedreference | Mulhall BP, Veerappan GR, Jackson JL. Meta-analysis: Computed tomographic colonography. Ann Intern Med 2005; 142: 635 – 50. | en_US |
dc.identifier.citedreference | Vijan S, Hwang EW, Hofer TP, Hayward RA. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am J Med 2001; 111: 593 – 601. | en_US |
dc.identifier.citedreference | Johnson DA, Gurney MS, Volpe RJ, et al. A prospective study of the prevalence of colonic neoplasms in asymptomatic patients with an age-related risk. Am J Gastroenterol 1990; 85: 969 – 74. | en_US |
dc.identifier.citedreference | DiSario JA, Foutch PG, Mai HD, et al. Prevalence and malignant potential of colorectal polyps in asymptomatic, average-risk men. Am J Gastroenterol 1991; 86: 941 – 45. | en_US |
dc.identifier.citedreference | Rickert RR, Auerback O, Garfinkel L, et al. Adenomatous lesions of the large bowel: An autopsy survey. Cancer 1979; 43: 1847 – 57. | en_US |
dc.identifier.citedreference | Blatt LJ. Polyps of the colon and rectum: Incidence and distribution. Dis Colon Rectum 1961; 4: 277 – 82. | en_US |
dc.identifier.citedreference | Arminski TC, McLean W. Incidence and distribution of adenomatous polyps of the colon and rectum based on 1,000 autopsy examinations. Dis Colon Rectum 1964; 7: 249 – 61. | en_US |
dc.identifier.citedreference | Myers M, Ries LAG. Cancer patient survival rates: SEER program results for 10 years of follow-up. CA Cancer J Clin 1989; 39: 21 – 32. | en_US |
dc.identifier.citedreference | Ahlquist DA, Wieand HS, Moertell CG, et al. Accuracy of fecal occult blood screening for colorectal neoplasia. JAMA 1993; 269: 1262 – 67. | en_US |
dc.identifier.citedreference | Mandel JS, Bond JH, Bradley M, et al. Sensitivity, specificity, and positive predictivity of the hemoccult test in screening for colorectal cancers. Gastroenterology 1989; 97: 597 – 600. | en_US |
dc.identifier.citedreference | Macrae FA, St. John DJB. Relationship between patterns of bleeding with hemoccult sensitivity in patients with colorectal cancers or adenomas. Gastroenterology 1982; 82: 891 – 8. | en_US |
dc.identifier.citedreference | Crowley ML, Feeman LD, Mottet MD, et al. Sensitivity of guaiac-impregnated cards for the detection of colorectal neoplasia. J Clin Gastroenterol 1983; 5: 127 – 30. | en_US |
dc.identifier.citedreference | Rex DK, Lehman GA, Hawes RH, et al. Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology 1991; 100: 64 – 7. | en_US |
dc.identifier.citedreference | Allison JE, Feldman R, Tekawa IS. Hemoccult screening in detecting colorectal neoplasm: Sensitivity, specificity, and predictive value. Ann Intern Med 1990; 112: 328 – 33. | en_US |
dc.identifier.citedreference | Niv Y, Sperber AD. Sensitivity, specificity, and predictive value of fecal occult blood testing (hemoccult II) for colorectal neoplasia in symptomatic patients: a prospective study with total colonoscopy. Am J Gastroenterol 1995; 90: 1974 – 7. | en_US |
dc.identifier.citedreference | Eddy DM. Screening for colorectal cancer. Ann Intern Med 1990; 113: 373 – 84. | en_US |
dc.identifier.citedreference | Foutch PG, Mai H, Pardy K, et al. Flexible sigmoidoscopy may be ineffective for secondary prevention of colorectal cancer in asymptomatic, average-risk men. Dig Dis Sci 1991; 36: 924 – 8. | en_US |
dc.identifier.citedreference | Lieberman DA, Smith FW. Screening for colon malignancy with colonoscopy. Am J Gastroenterol 1991; 86: 946 – 51. | en_US |
dc.identifier.citedreference | Rex DK, Cutler CS, Lemmel GT, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997; 112: 24 – 8. | en_US |
dc.identifier.citedreference | Hixson LJ, Fennerty MB, Sampliner RE, et al. Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointest Endosc 1991; 37: 125 – 7. | en_US |
dc.identifier.citedreference | Rex DK. Colonoscopy. a review of its yield for cancers and adenomas by indication. Am J Gastroenterol 1995; 90: 353 – 65. | en_US |
dc.identifier.citedreference | Castiglione G, Mazzotta A, Grazzini G. Sensitivity of screening sigmoidoscopy for proximal colorectal tumours (letter). Lancet 1995; 345: 726 – 7. | en_US |
dc.identifier.citedreference | Zarchy TM, Ershoff D. Do characteristics of adenomas on flexible sigmoidoscopy predict advanced lesions on baseline colonoscopy? Gastroenterology 1994; 106: 1501 – 4. | en_US |
dc.identifier.citedreference | Achkar E, Carey W. Small polyps found during fiberoptic sigmoidoscopy in asymptomatic patients. Ann Intern Med 1988; 109: 880 – 3. | en_US |
dc.identifier.citedreference | Habr-Gama A, Waye JD. Complications and hazards of gastrointestinal endoscopy. World J Surg 1989; 13: 193 – 201. | en_US |
dc.identifier.citedreference | Macrae FA, Tan KG, Williams CB. Towards safer colonoscopy: A report on the complications of 5000 diagnostic or therapeutic colonoscopies. Gut 1983; 24: 376 – 83. | en_US |
dc.identifier.citedreference | Waye JD, Lewis BS, Yessayan S. Colonoscopy: A prospective report of complications. J Clin Gastroenterol 1992; 15: 347 – 51. | en_US |
dc.identifier.citedreference | Eddy DM, Nugent FW, Eddy JF, et al. Screening for colorectal cancer in a high-risk population. Gastroenterology 1987; 92: 682 – 92. | en_US |
dc.identifier.citedreference | 41. Department of Health and Human Services, Centers for Medicare and Medicaid Services: Medicare Program: Physician Fee Schedule Update for Calendar Year 2003. Federal Register 2003; 68: 9567 – 80. | en_US |
dc.identifier.citedreference | 42. Department of Health and Human Services HCFA. Medicare program; revisions to payment policies and five-year review of and adjustments to the relative value units under the physician fee schedule for calendar year 2000 and physician volume performance standard rates of increase for federal fiscal year 1999, notice. Federal Register 1999; 64: 59379 – 428. | en_US |
dc.identifier.citedreference | Rogge JD, Elmore MF, Mahoney SJ, et al. Low-cost, office-based, screening colonoscopy. Am J Gastroenterol 1994; 89: 1775 – 80. | en_US |
dc.identifier.citedreference | Wagner JL, Tunis S, Brown M, et al. Cost-effectiveness of colorectal cancer screening in average-risk adults. In: Young GP, Rozen P, Levin B, eds. Prevention and early detection of colorectal cancer. Philadelphia: WB Saunders, 1996. pp. 321 – 41. | en_US |
dc.identifier.citedreference | Fireman BH, Quesenberry CP, Somkin CP, et al. Cost of care for cancer in a health maintenance organization. Helath Care Financing Rev 1997; 18: 51 – 76. | en_US |
dc.identifier.citedreference | Baker MS, Kessler LG, Smucker RC. Site-Specific Treatment Costs for Cancer: An Analysis of the Medicare Continuous History Sample File. In: Scheffler, RM, Andrews NC, eds. Cancer Care and Costs: DRGs and Beyond. Ann Arbor, Michigan: Health Administration Press, 1989. pp. 127 – 38. | en_US |
dc.identifier.citedreference | Pignone M, Russell L, and Wagner J. Economic models of colorectal cancer screening in average risk adults. 2005. Washington, DC, The National Academies Press. | en_US |
dc.identifier.citedreference | Taplin SH, Barlow W, Urban N, et al. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care. J Natl Cancer Inst 1995; 87: 417 – 26. | en_US |
dc.identifier.citedreference | Frazier AL, Colditz GA, Fuchs CS, et al. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 2000; 284: 1954 – 61. | en_US |
dc.identifier.citedreference | Loeve F, Brown ML, Boer R, et al. Endoscopic colorectal cancer screening: a cost-saving analysis. J Natl Cancer Inst 2000; 92: 557 – 63. | en_US |
dc.identifier.citedreference | Khandker RK, Dulski JD, Kilpatrick JB, et al. A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults. Int J Technol Assess Health Care 2000; 16: 799 – 810. | en_US |
dc.identifier.citedreference | Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 2000; 133: 573 – 84. | en_US |
dc.identifier.citedreference | 53. National Center for Health Statistics. Vital statistics of the United States, 1991, vol II, mortality, part B. Washington, DC: Public Health Service, 1995. | en_US |
dc.identifier.citedreference | Eide TJ. Remnants of adenomas in colorectal carcinomas. Cancer 1983; 51: 1866 – 72. | en_US |
dc.identifier.citedreference | Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997; 112: 594 – 642. | en_US |
dc.identifier.citedreference | Selby JV, Friedman GD, Quesenberry CP, et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992; 326: 653 – 57. | en_US |
dc.identifier.citedreference | Cauffman JG, Hara JH, Rasgon IM, et al. Flexible sigmoidoscopy in asymptomatic patients with negative fecal occult blood tests. J Fam Pract 1992; 34: 281 – 6. | en_US |
dc.identifier.citedreference | Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328: 1365 – 71. | en_US |
dc.identifier.citedreference | Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472 – 7. | en_US |
dc.identifier.citedreference | Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467 – 71. | en_US |
dc.identifier.citedreference | Squillace S, Berggreen P, Jaffe P, et al. A normal initial colonoscopy after age 50 does not predict a polyp-free status for life. Am J Gastroenterol 1994; 89: 1156 – 9. | en_US |
dc.identifier.citedreference | Rex DK, Cummings OW, Helper DJ, et al. 5-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons. Gastroenterology 1996; 111: 1178 – 81. | en_US |
dc.identifier.citedreference | Rex DK, Lehman GA, Ulbright TM, et al. The yield of a second screening flexible sigmoidoscopy in average- risk persons after one negative examination. Gastroenterology 1994; 106: 593 – 5. | en_US |
dc.identifier.citedreference | Noshirwani KC, van Stolk RU, Rybicki LA, et al. Adenoma size and number are predictive of adenoma recurrence: Implications for surveillance endoscopy. Gastrointest Endosc 2000; 51: 433 – 7. | en_US |
dc.identifier.citedreference | Winawer SJ, Zauber AG, O'Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med 1993; 328: 901 – 5. | en_US |
dc.identifier.citedreference | Pickhardt PJ, Choi JR, Hwang I, et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003; 349: 2191 – 200. | en_US |
dc.identifier.citedreference | Critchfield GC, Willard KE. Probabilistic analysis of decision trees using Monte Carlo simulation. Med Decis Making 1986; 6: 85 – 92. | en_US |
dc.identifier.citedreference | Manning WG, Fryback DG, Weinstein MC. Reflecting uncertainty in Cost-effectiveness analysis. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996. pp. 247 – 75. | en_US |
dc.identifier.citedreference | Laupacis A, Feeny D, Detsky AS, et al. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ 1992; 146: 473 – 81. | en_US |
dc.identifier.citedreference | Hirth RA, Chernew ME, Miller E, et al. Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making 2000; 20: 332 – 42. | en_US |
dc.identifier.citedreference | Ladabaum U, Song K, Fendrick AM. Colorectal neoplasia screening with virtual colonoscopy: when, at what cost, and with what national impact? Gastroenterol Hepatol 2004; 2: 554 – 63. | en_US |
dc.identifier.citedreference | Ransohoff DF. Virtual colonoscopy–What it can do vs. what it will do. JAMA 2004; 291: 1772 – 4. | en_US |
dc.identifier.citedreference | Cotton PB, Durkalski VL, Pineau BC, et al. Computed tomographic colonography (virtual colonoscopy): A multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA 2004; 291: 1713 – 9. | en_US |
dc.identifier.citedreference | Rockey DC, Paulson E, Niedzwiecki D, et al. Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison. Lancet 2005; 365: 305 – 11. | en_US |
dc.identifier.citedreference | Brenner DJ, Elliston CD. Estimated radiation risks potentially associated with full-body CT screening. Radiology 2004; 232: 735 – 8. | en_US |
dc.identifier.citedreference | Vijan S, Inadomi J, Hayward RA, et al. Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States. Aliment Pharmacol Ther 2004; 20: 507 – 15. | en_US |
dc.identifier.citedreference | Kolata G. 50 and ready for Colonoscopy? doctors say wait is often long. A(1), 1. 2003. New York, NY, New York Times. | en_US |
dc.identifier.citedreference | Brown ML, Klabunde CN, Mysliwiec P. Current capacity for endoscopic colorectal cancer screening in the United States: Data from the National Cancer Institute survey of colorectal cancer screening practices. Am J Med 2003; 115: 129 – 33. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.